Centessa Pharmaceuticals plc shifts focus to ORX750 for sleep disorders after discontinuing SerpinPC. Click here to find out ...

Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...

Stackhouse was diagnosed with narcolepsy during his first year at Georgia, where he started 42 games and won two national ...

ANSWER: When we are in dream sleep (also called REM sleep), the body’s muscles are essentially turned “off” by the brain. If ...

The randomised trial saw more than half of patients dosed with Sunosi achieving clinical response to the therapy used to ...

When the NFL suspended Rams wide receiver Drake Stoops two games for violating the league policy on performance-enhancing ...

Avadel Pharmaceuticals (AVDL) announced the publication of six manuscripts covering clinical management, shared decision-making and goal ...

Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...

I am delighted to serve as guest editor for the recently published CNS Drugs supplement, focused on key clinical issues for people with narcolepsy and their clinicians with a particular emphasis on ...

Kat Abughazaleh is a dynamic 26-year-old political commentator whos making waves on social media. She is stepping up to run ...

WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...